A vesesejtes daganatok célzott terápiás kezelése, a terápia okozta mellékhatások és ellátásuk

Translated title of the contribution: Targeted treatment of renal cell carcinoma, treatment caused side-effects and side-effect management

Nagyiványi Krisztián, L. Géczi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Until the past decade, therapeutic options for unresectable and/or metastatic renal cell carcinoma were limited. Renal cell carcinoma is generally resistant to conventional chemotherapy, and only a small percentage of patients with renal cell carcinoma benefit from cytokine treatment. Since 2005, the advances in target-based therapy and immunotherapy modalities have created a paradigm shift in the treatment of renal cell carcinoma. Herein, we review the most up-to-date practices and emerging therapies for the treatment of renal cell carcinoma and focus on the threrapy caused side-effects and side-effect management.

Translated title of the contributionTargeted treatment of renal cell carcinoma, treatment caused side-effects and side-effect management
Original languageHungarian
Pages (from-to)1488-1502
Number of pages15
JournalOrvosi Hetilap
Volume158
Issue number38
DOIs
Publication statusPublished - Sep 1 2017

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Targeted treatment of renal cell carcinoma, treatment caused side-effects and side-effect management'. Together they form a unique fingerprint.

  • Cite this